What are the clinical implications of IDH2 mutations?
The presence of IDH2 mutations in cancer can have significant clinical implications. These mutations are often associated with a distinct clinical and biological profile, which can influence prognosis and treatment decisions. For example, in AML, IDH2 mutations are generally associated with intermediate-risk disease and can predict response to targeted therapies.
